Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases

Medicine & Life Sciences

• Chronic Obstructive Pulmonary Disease 100%
• Cardiovascular Diseases 81%
• Angiotensin II Type 1 Receptor Blockers 18%
• Arteritis 18%
• Morbidity 16%
• Vascular Stiffness 16%
• Therapeutics 16%
• Bronchodilator Agents 15%
• Smoking Cessation 14%
• Angiotensin-Converting Enzyme Inhibitors 13%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 13%
• Smoke 13%
• Adrenergic Receptors 13%
• Tobacco Products 13%
• Pneumonia 11%
• Adrenal Cortex Hormones 11%
• Blood Platelets 10%
• Hospitalization 10%
• Inflammation 8%
• Survival 7%
• Lung 7%
• Mortality 7%
• Pharmaceutical Preparations 5%